Study ID: UP-AA.
A clinical trial for Alopecia Areata
Summary
Even when losing our hair feels like losing everything, we can’t lose hope for a better future.
This study is designed to evaluate the safety and efficacy of an investigational drug compared to a placebo in achieving hair regrowth and improving the quality of life for participants living with alopecia areata.
Participants receive either the investigational drug or a placebo (something that looks like the investigational drug but has no effect on the body), both administered orally (by mouth).
Study medicine and any trial related procedures or care are provided at no cost.
Your participation in this clinical trial for alopecia may help develop treatments that may help millions of people.
If you want to help us research innovative treatments by trying them with us, read on to the inclusion criteria.
There are other criteria that our clinical staff will discuss with you as well.
Inclusion Criteria
You are eligible* to participate in the study if:
Between the ages of 12-63
Have severe patchy hair loss from alopecia.
Have not been diagnosed with other causes of hair loss (including male or female pattern baldness)
* Additional criteria for eligibility apply
If study investigators determine you are eligible, your participation in this clinical trial may help find a potential treatment option for you and others with severe hair loss from this condition.
If you participate in this clinical research study, You will be asked to:**
Provide signed informed consent
Comply with all scheduled clinic
visits and study-related
procedures
Not take any study-prohibited
medications during the trial
period
** Additional responsibilities apply
Your participation in the study is entirely voluntary, and your information
will be confidential. If you change your mind, you can withdraw from the study at any
time, for any reason, and without any consequence
What to expect during the study
This research study will last up to 160 weeks (about 3 years). Participants will be assigned randomly to receive either the investigational drug or a placebo.
After the first 24 weeks (about 6 months) of this study treatment period, some participants will continue to receive their assigned study drug (investigational or placebo) for another 28 weeks (about 7 months) while some participants receiving the placebo will be randomly assigned to receive the investigational drug.
After the end of this second period, some participants will continue to receive their treatment, and some participants receiving the investigational drug will be given
Contact us about joining the trial
To be eligible for this trial, applicants MUST have alopecia. We DO NOT accept volunteers who do not have a skin disease.
Fill out this form, or call us to get in touch. Our phone number is # (289)-763-8666.
We will contact you in 1-2 business days regarding your application to participate in the trial.
Privacy Policy for SimcoDerm Clinical Trials
Your privacy is important to us, and we take the protection of your personal health information (PHI) seriously. This policy explains how we collect, use, and protect your information.
We collect information directly from you, including your name, contact details, health information, and treatment history.
We use your information to determine eligibility for clinical trials, manage appointments, and communicate with you about your participation in clinical trials.
Data Protection:
Your information is stored securely and is only accessible by authorized personnel. We use data encryption, conduct security audits, and implement strict access controls to ensure the protection of your personal information.
You have the right to access, amend, or request the deletion of your health records. To exercise these rights, send a request to our clinical trial support team.